DISEASE SCANNER
Global Incurable Diseases Tracker
Systemic Sclerosis (Scleroderma)
A chronic autoimmune disease causing fibrosis of skin and internal organs (diffuse cutaneous) or primarily skin (limited cutaneous/CREST). Characterized by vasculopathy and immune activation. Limited form associated with anti-centromere antibodies, diffuse with anti-Scl-70.
300.0K
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Autoantibody testing
- 2Inflammatory markers
- 3Imaging
- 4Biopsy
- 5Clinical criteria
- 6Exclusion of other causes
Prognosis
Variable; many autoimmune diseases are chronic with relapsing-remitting courses. Early treatment and modern biologics have significantly improved outcomes.
Prevention
- No specific prevention
- Smoking cessation
- Avoidance of triggers
- Early diagnosis and treatment
- Regular monitoring
Research Status
Nintedanib and tocilizumab for ILD. Tocilizumab and mycophenolate effective. Autologous stem cell transplant for severe diffuse disease. ACE inhibitors for scleroderma renal crisis.
Affected Countries
Sources
- https://www.ncbi.nlm.nih.gov/books/NBK519046
- https://www.ncbi.nlm.nih.gov/books
- https://www.mayoclinic.org/diseases-conditions
- https://rarediseases.org/rare-diseases
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.